CDC investigators looked at what might cause reinfections during the first wave of the pandemic.
Before the arrival of various variants of COVID-19, such as the Delta variant, reinfection of health care professionals and first responders over a 9-month period was fairly uncommon, according to a study in Clinical Infectious Diseases. Investigators with the Centers for Disease Control and Prevention (CDC) looked at serology surveys and viral testing results of participants from Rhode Island from March 1, 2020, to February 17, 2021, and for New York City participants from March 10, 2020, to December 14, 2020. The rollout of vaccines began December 14, 2020, in both jurisdictions but vaccine data were not used in this study, and symptom data were also unavailable.
“Seropositivity decreased reinfection risk,” the study states. “Lower reinfection risk associated with exposure to a household member with COVID-19 before the serosurvey may reflect subsequently reduced household transmission among members of previously infected households.”
Included in the study were individuals who tested positive for SARS-CoV-2 14 or more days after their first serology test. The CDC investigators defined reinfection as a second positive test 90 or more days after the first positive test.
“The association between serostatus and reinfection was assessed with a proportional hazards model adjusting for demographics, exposures, and virus testing frequency,” the study states.
Of 1572 participants who’d been infected with SARS-CoV-2, 40 (2.5%) were reinfected. Reinfections for seropositive participants was 1.9%; while 8.4% of seronegative participants were reinfected. Most of the reinfections occurred among nursing home residents and corrections personnel in Rhode Island (n=30). They were also tested the most, with a mean testing rate of 30.3 tests as opposed to 4.6 for other Rhode Island and New York City participants.
The greater number of tests in Rhode Island sprung from the CDC mandating routine periodic testing for nursing home residents and staff. The Rhode Island Department of Health conducted frequent testing among prison personnel because of COVID-19 outbreaks in those institutions.
“Although increased testing frequency was mandated in New York skilled nursing facilities, nursing home personnel were not included in the New York City serosurvey,” the study states.
The adjusted hazard ratio (aHR) for reinfection in seropositive versus seronegative persons was 0.41 (95% CI 0.20, 0.81),” the study states. “Exposure to a household member with COVID-19 before the serosurvey was also protective (aHR 0.34, 95% CI 0.13, 0.89).”
Individuals who reported exposure to a household member with COVID-19 prior to the serology survey were less likely to be reinfected. Reinfection was not associated with other risk factors such as underlying health conditions.
“Studies of health care personnel have found that community transmission was a strong risk factor for initial infection,” the study states. “Persons initially infected in their households may have a lower risk of subsequent household infection if household members also developed immunity.”
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.